Skip to content
The People's CodeSearch
Menu

Changes to the Code

H.R. 6182 · Find It Early Act ·

In committee · step 2 of 5

Sections are cited like “7 U.S.C. § 2012”: 7 of the , 2012.

10 U.S.C. § 1074d Certain primary and preventive health care services

+2 −0Shown
More for 10 U.S.C. § 1074d
Read § 1074dOnly this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    in section 1074d(a), by adding at the end the following new paragraph:(3) Any member or former member of the uniformed services who is entitled to medical care under section 1074 or 1074a of this title and is an individual described in subparagraph (B) of section 1079(a)(20) of this title shall also be entitled to the items and services described …

§ 1074d(a)–(b)

§ 1074d. Certain primary and preventive health care services

(a) Services Available.—

(1) Female members and former members of the uniformed services entitled to medical care under section 1074 or 1074a of this title shall also be entitled to primary and preventive health care services for women as part of such medical care. The services described in paragraphs (1) and (2) of subsection (b) shall be provided under such procedures and at such intervals as the Secretary of Defense shall prescribe.

(2) Male members and former members of the uniformed services entitled to medical care under section 1074 or 1074a of this title shall also be entitled to preventive health care screening for colon or prostate cancer at such intervals and using such screening methods as the administering Secretaries consider appropriate.

(3) [inserted: Any member or former member of the uniformed services who is entitled to medical care under section 1074 or 1074a of this title and is an individual described in subparagraph (B) of section 1079(a)(20) of this title shall also be entitled to the items and services described in subparagraph (A) of such section (subject to the same limitations specified in such subparagraph), as part of such medical care.]

(b) Definition.— In this section, the term “primary and preventive health care services for women” means health care services, including related counseling services, provided to women with respect to the following:

(1) Cervical cancer screening.

Rest of § 1074d unchanged ·

10 U.S.C. § 1079 Contracts for medical care for spouses and children: plans

+9 −0Shown
More for 10 U.S.C. § 1079
Read § 1079Only this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    in section 1079(a), by adding at the end the following new paragraph:(21) (A) Screening and diagnostic imaging for the detection of breast cancer, including 2D or 3D mammograms, breast ultrasounds, breast magnetic resonance imaging, molecular breast imaging, contrast-enhanced mammography, or other technologies (as determined in accordance with …

§ 1079(a)–(b)

Start of § 1079 to (a)(19)(E) unchanged ·

(F) Conditions linked with Ashkenazi Jewish descent.

(20) Medical interventions for the treatment of gender dysphoria that could result in sterilization may not be provided to a child under the age of 18.

(21)

(A) [inserted: Screening and diagnostic imaging for the detection of breast cancer, including 2D or 3D mammograms, breast ultrasounds, breast magnetic resonance imaging, molecular breast imaging, contrast-enhanced mammography, or other technologies (as determined in accordance with the most recent applicable criteria or guidelines described in subparagraph (B)), shall be provided at such frequency as is recommended in guidelines set forth by the National Comprehensive Cancer Network if the patient is an individual described in subparagraph (B).]

(B) [inserted: An individual described in this subparagraph is—]

(i) [inserted: an individual who is at increased risk of breast cancer (as determined in accordance with the most recent applicable American College of Radiology Appropriateness Criteria or the most recent applicable guidelines of the National Comprehensive Cancer Network) or with heterogeneously or extremely dense breast tissue (as defined by the Breast Imaging Reporting and Data System established by the American College of Radiology); or]

(ii) [inserted: an individual who is not described in clause (i) and who is determined by a health care provider (in accordance with such most recent applicable criteria or guidelines) to require screening or diagnostic breast imaging by reason of factors including age, race, ethnicity, or personal or family medical history.]

(b) Plans covered by subsection (a) shall include provisions for payment by the patient of the following amounts:

(1) $25 for each admission to a hospital, or the amount the patient would have been charged under section 1078(a) of this title had the care being paid for been obtained in a hospital of the uniformed services, whichever amount is the greater. The Secretary of Defense may exempt a patient from paying such amount if the hospital to which the patient is admitted does not impose a legal obligation on any of its patients to pay for inpatient care.

Rest of § 1079 unchanged ·

26 U.S.C. § 9826 Coverage of breast screenings for certain individuals at increased risk for breast cancer New section

+6 −0Shown
More for 26 U.S.C. § 9826
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Subchapter B of chapter 100 of the Internal Revenue Code of 1986 is amended by adding at the end the following new section:9826. Coverage of breast screenings for certain individuals at increased risk for breast cancer With respect to plan years beginning on or after January 1, 2026, a group health plan shall provide coverage and shall not impose any cost sharing requirements for— (1) with respect to an individual who is at increased risk of breast cancer (as determined in accordance with the most recent applicable American College of Radiology Appropriateness Criteria or the most recent applicable guidelines of the National Comprehensive Cancer Network) or with heterogeneously or extremely dense breast tissue (as defined by the Breast Imaging Reporting and Data System established by the American College of Radiology), screening and diagnostic imaging for the detection of breast cancer, including 2D or 3D mammograms, breast ultrasounds, breast magnetic resonance imaging, molecular breast imaging, contrast-enhanced mammography, or other technologies (as determined in accordance with such applicable criteria or guidelines), furnished at such frequency as is recommended in guidelines set forth by the National Comprehensive Cancer Network; and (2) with respect to an individual who is not described in paragraph (1) and who is determined by a health care provider (in accordance with such most recent applicable criteria or guidelines) to require screening or diagnostic breast imaging by reason of factors, including age, race, ethnicity, or personal or family medical history, screening and diagnostic imaging for the detection of breast cancer, including 2D or 3D mammograms, breast ultrasounds, breast magnetic resonance imaging, molecular breast imaging, contrast-enhanced mammography, or other technologies (as determined in accordance with such applicable criteria or guidelines), furnished at such frequency as is recommended in guidelines set forth by the National Comprehensive Cancer Network..

    The section already has a provision under this letter or number, so it would have two.

The Code already has a 26 U.S.C. § 9826, a different section added since this bill was written, so this would be a second section under that number.

§ 9826(1)–(2)

§ 9826. [inserted: Coverage of breast screenings for certain individuals at increased risk for breast cancer]

[inserted: With respect to plan years beginning on or after January 1, 2026, a group health plan shall provide coverage and shall not impose any cost sharing requirements for—]

(1) [inserted: with respect to an individual who is at increased risk of breast cancer (as determined in accordance with the most recent applicable American College of Radiology Appropriateness Criteria or the most recent applicable guidelines of the National Comprehensive Cancer Network) or with heterogeneously or extremely dense breast tissue (as defined by the Breast Imaging Reporting and Data System established by the American College of Radiology), screening and diagnostic imaging for the detection of breast cancer, including 2D or 3D mammograms, breast ultrasounds, breast magnetic resonance imaging, molecular breast imaging, contrast-enhanced mammography, or other technologies (as determined in accordance with such applicable criteria or guidelines), furnished at such frequency as is recommended in guidelines set forth by the National Comprehensive Cancer Network; and]

(2) [inserted: with respect to an individual who is not described in paragraph (1) and who is determined by a health care provider (in accordance with such most recent applicable criteria or guidelines) to require screening or diagnostic breast imaging by reason of factors, including age, race, ethnicity, or personal or family medical history, screening and diagnostic imaging for the detection of breast cancer, including 2D or 3D mammograms, breast ultrasounds, breast magnetic resonance imaging, molecular breast imaging, contrast-enhanced mammography, or other technologies (as determined in accordance with such applicable criteria or guidelines), furnished at such frequency as is recommended in guidelines set forth by the National Comprehensive Cancer Network.]

38 U.S.C. § 1720M Breast screenings for certain individuals at increased risk for breast cancer New section

+12 −0Shown
More for 38 U.S.C. § 1720M
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Subchapter II of chapter 17 of title 38, United States Code, is amended by inserting after section 1720L the following new section:1720M. Breast screenings for certain individuals at increased risk for breast cancer (a) Coverage of items and services.— (1) Coverage.— The Secretary shall furnish to a veteran described in paragraph (2) screening and diagnostic imaging for the detection of breast cancer, including 2D or 3D mammograms, breast ultrasounds, breast magnetic resonance imaging, molecular breast imaging, contrast-enhanced mammography, or other technologies (as determined in accordance with the most recent applicable criteria or guidelines described in such paragraph) at such frequency as is recommended in guidelines set forth by the National Comprehensive Cancer Network pursuant to this section. (2) Eligibility.— A veteran described in this paragraph is— (A) a veteran who is at increased risk of breast cancer (as determined in accordance with the most recent applicable American College of Radiology Appropriateness Criteria or the most recent applicable guidelines of the National Comprehensive Cancer Network) or with heterogeneously or extremely dense breast tissue (as defined by the Breast Imaging Reporting and Data System established by the American College of Radiology), without regard to whether the veteran is enrolled in the system of annual patient enrollment established and operated under section 1705(a) of this title; or (B) a veteran who is not described in subparagraph (A) and who is determined by a health care provider (in accordance with such most recent applicable criteria or guidelines) to require screening or diagnostic breast imaging by reason of factors including age, race, ethnicity, or personal or family medical history, without regard to whether the veteran is enrolled in the system of annual patient enrollment established and operated under section 1705(a) of this title. (b) Prohibition on cost-Sharing.— Notwithstanding subsections (f) and (g) of section 1710 and section 1722A of this title, the Secretary may not require any veteran described in paragraph (2) of subsection (a) to make any copayment for, or charge the veteran for any other cost of, the receipt of any item or service furnished pursuant to paragraph (1) of such subsection..

§ 1720M(a)–(b)

§ 1720M. [inserted: Breast screenings for certain individuals at increased risk for breast cancer]

(a) [inserted: Coverage of items and services.—]

(1) [inserted: Coverage.—] [inserted: The Secretary shall furnish to a veteran described in paragraph (2) screening and diagnostic imaging for the detection of breast cancer, including 2D or 3D mammograms, breast ultrasounds, breast magnetic resonance imaging, molecular breast imaging, contrast-enhanced mammography, or other technologies (as determined in accordance with the most recent applicable criteria or guidelines described in such paragraph) at such frequency as is recommended in guidelines set forth by the National Comprehensive Cancer Network pursuant to this section.]

(2) [inserted: Eligibility.—] [inserted: A veteran described in this paragraph is—]

(A) [inserted: a veteran who is at increased risk of breast cancer (as determined in accordance with the most recent applicable American College of Radiology Appropriateness Criteria or the most recent applicable guidelines of the National Comprehensive Cancer Network) or with heterogeneously or extremely dense breast tissue (as defined by the Breast Imaging Reporting and Data System established by the American College of Radiology), without regard to whether the veteran is enrolled in the system of annual patient enrollment established and operated under section 1705(a) of this title; or]

(B) [inserted: a veteran who is not described in subparagraph (A) and who is determined by a health care provider (in accordance with such most recent applicable criteria or guidelines) to require screening or diagnostic breast imaging by reason of factors including age, race, ethnicity, or personal or family medical history, without regard to whether the veteran is enrolled in the system of annual patient enrollment established and operated under section 1705(a) of this title.]

(b) [inserted: Prohibition on cost-Sharing.—] [inserted: Notwithstanding subsections (f) and (g) of section 1710 and section 1722A of this title, the Secretary may not require any veteran described in paragraph (2) of subsection (a) to make any copayment for, or charge the veteran for any other cost of, the receipt of any item or service furnished pursuant to paragraph (1) of such subsection.]

42 U.S.C. § 1395w–22 Benefits and beneficiary protections

+5 −3Shown
More for 42 U.S.C. § 1395w–22
Read § 1395w–22Only this section
3 changes the bill asks for here, 3 carried out
  1. Carried out:

    by redesignating subclause (VIII) as subclause (IX); and

  2. Carried out:

    by inserting after subclause (VII) the following:(VIII) Beginning on January 1, 2026, screening and diagnostic imaging and other technologies described in section 1861(ddd)(1)(B)(ii) furnished not more frequently than is recommended in guidelines set forth by the National Comprehensive Cancer Network to an individual described in such section.; and

  3. Carried out:

    in clause (v), by striking and (VI) and inserting (VI), and (VIII).

§ 1395w–22(a)Basic benefits(1)–(2)

Start of § 1395w–22 to (a)(1)(B)(iv)(V) unchanged ·

(VI) A COVID–19 vaccine and its administration described in section 1395x(s)(10)(A) of this title.

(VII) A drug or biological product that is a selected drug (as referred to in section 1320f–1(c) of this title).

(VIII) [inserted: Beginning on January 1, 2026, screening and diagnostic imaging and other technologies described in section 1861(ddd)(1)(B)(ii) furnished not more frequently than is recommended in guidelines set forth by the National Comprehensive Cancer Network to an individual described in such section.]

[struck: (VIII)] [inserted: (IX)] Such other services that the Secretary determines appropriate (including services that the Secretary determines require a high level of predictability and transparency for beneficiaries).

(v) Exception In the case of services described in clause (iv), other than subclauses (IV), (V), [inserted: (VI), ]and ([struck: VI][inserted: VIII]) of such clause, for which there is no cost-sharing required under parts A and B, cost-sharing may be required for those services in accordance with clause (i).

(vi) Prohibition of application of certain requirements for COVID–19 testing In the case of a product or service described in subclause (IV) or (V), respectively, of clause (iv) that is administered or furnished during any portion of the emergency period described in such subclause beginning on or after March 18, 2020, an MA plan may not impose any prior authorization or other utilization management requirements with respect to the coverage of such a product or service under such plan.

(2) Satisfaction of requirement

Rest of § 1395w–22 unchanged ·

42 U.S.C. § 1395x Definitions

+7 −12 of 3 shown
More for 42 U.S.C. § 1395x
Read § 1395xOnly this section
3 changes the bill asks for here, 2 carried out
  1. Not carried out:

    by striking (B) recommended and inserting (B)(i) recommended;

    “(B) recommended” isn't in § 1395x(ddd)(1)(B) in the Code as we have it. The law may have changed since the bill was drafted.

    Technical detail“(B) recommended” not found in /us/usc/t42/s1395x/ddd/1/B
  2. Carried out:

    by striking Task Force; and and inserting Task Force; or; and

  3. Carried out:

    by adding at the end the following new clause:(ii) with respect services furnished on or after January 1, 2026, screening and diagnostic imaging for the detection of breast cancer, including 2D or 3D mammograms, breast ultrasounds, breast magnetic resonance imaging, molecular breast imaging, contrast-enhanced mammography, …

§ 1395x(ddd)Additional preventive services; preventive services(1)–(2)

Start of § 1395x to (ddd)(1) unchanged ·

(A) reasonable and necessary for the prevention or early detection of an illness or disability;

(B) recommended with a grade of A or B by the United States Preventive Services Task Force; [struck: and][inserted: or]

(C) appropriate for individuals entitled to benefits under part A or enrolled under part B.

(2) In making determinations under paragraph (1) regarding the coverage of a new service, the Secretary shall use the process for making national coverage determinations (as defined in section 1395ff(f)(1)(B) of this title) under this subchapter. As part of the use of such process, the Secretary may conduct an assessment of the relation between predicted outcomes and the expenditures for such service and may take into account the results of such assessment in making such determination.

§ 1395x(ddd)–(eee)

(ddd)(3) unchanged ·

(B) An initial preventive physical examination (as defined in subsection (ww)).

(C) Personalized prevention plan services (as defined in subsection (hhh)(1)).

(ii) [inserted: with respect services furnished on or after January 1, 2026, screening and diagnostic imaging for the detection of breast cancer, including 2D or 3D mammograms, breast ultrasounds, breast magnetic resonance imaging, molecular breast imaging, contrast-enhanced mammography, or other technologies (as determined in accordance with the most recent applicable American College of Radiology Appropriateness Criteria or the most recent applicable guidelines of the National Comprehensive Cancer Network), furnished not more frequently than is recommended in guidelines set forth by the National Comprehensive Cancer Network to—]

(I) [inserted: an individual who is at increased risk of breast cancer (as determined in accordance with such applicable criteria or guidelines) or with heterogeneously or extremely dense breast tissue (as defined by the Breast Imaging Reporting and Data System established by the American College of Radiology); or]

(II) [inserted: an individual who is not described in subclause (I) and who is determined by a health care provider (in accordance with such most recent applicable criteria or guidelines) to require such screening or diagnostic breast imaging by reason of factors determined by the Secretary, including age, race, ethnicity, or personal or family medical history; and]

(eee) Cardiac rehabilitation program; intensive cardiac rehabilitation program

(1) The term “cardiac rehabilitation program” means a program (as described in paragraph (2)) that furnishes the items and services described in paragraph (3) under the supervision of a physician (as defined in subsection (r)(1)) or a physician assistant, nurse practitioner, or clinical nurse specialist (as those terms are defined in subsection (aa)(5)).

Rest of § 1395x unchanged ·

42 U.S.C. § 1396d Definitions

+2 −2Shown
More for 42 U.S.C. § 1396d
Read § 1396dOnly this section
5 changes the bill asks for here, 5 carried out
  1. Carried out:

    by striking ; and (D) and inserting ; (D);

  2. Carried out:

    by striking ; and (E) and inserting ; (E);

  3. Carried out:

    by striking ; and (F) and inserting ; (F); and

  4. Carried out:

    by inserting before the semicolon at the end the following: ; and (G)(i) with respect to an individual who is at increased risk of breast cancer (as determined in accordance with the most recent applicable American College of Radiology Appropriateness Criteria or the most recent applicable guidelines of the National Comprehensive Cancer Network) or with heterogeneously or extremely dense breast tissue (as defined by the Breast Imaging Reporting and Data System established by the American College of Radiology), in addition to any other item or service described in this subsection, screening and diagnostic imaging for the detection of breast cancer, including 2D or 3D mammograms, breast ultrasounds, breast magnetic resonance imaging, molecular breast imaging, contrast-enhanced mammography, or other technologies (as determined in accordance with such applicable criteria or guidelines) furnished not more frequently than is recommended in guidelines set forth by the National Comprehensive Cancer Network; and (ii) with respect to an individual who is not described in clause (i) and who is determined by a health care provider (in accordance with such most recent applicable criteria or guidelines) to require screening or diagnostic breast imaging by reason of factors, including age, race, ethnicity, or personal or family medical history, screening and diagnostic imaging for the detection of breast cancer, including 2D or 3D mammograms, breast ultrasounds, breast magnetic resonance imaging, molecular breast imaging, contrast-enhanced mammography, or other technologies (as determined in accordance with such applicable criteria or guidelines) furnished not more frequently than is recommended in guidelines set forth by the National Comprehensive Cancer Network; and

  5. Carried out:

    in paragraph (13), in the matter preceding subparagraph (A), by inserting (other than an item or service for which medical assistance is provided pursuant to paragraph (4)(G)) after services.

§ 1396d(a)Medical assistance(3)–(5)

Start of § 1396d to (a)(3)(A) unchanged ·

(B) in vitro diagnostic products (as defined in section 809.3(a) of title 21, Code of Federal Regulations) administered during any portion of the emergency period defined in paragraph (1)(B) of section 1320b–5(g) of this title beginning on or after March 18, 2020, for the detection of SARS–CoV–2 or the diagnosis of the virus that causes COVID–19, and the administration of such in vitro diagnostic products;

(4)

(A) nursing facility services (other than services in an institution for mental diseases) for individuals 21 years of age or older; (B) early and periodic screening, diagnostic, and treatment services (as defined in subsection (r)) for individuals who are eligible under the plan and are under the age of 21; (C) family planning services and supplies furnished (directly or under arrangements with others) to individuals of child-bearing age (including minors who can be considered to be sexually active) who are eligible under the State plan and who desire such services and supplies; [struck: and ](D) counseling and pharmacotherapy for cessation of tobacco use by pregnant women (as defined in subsection (bb)); [struck: and ](E) during the period beginning on March 11, 2021, and ending on the last day of the first calendar quarter that begins one year after the last day of the emergency period described in section 1320b–5(g)(1)(B) of this title, a COVID–19 vaccine and administration of the vaccine; [struck: and ](F) during the period beginning on March 11, 2021, and ending on the last day of the first calendar quarter that begins one year after the last day of the emergency period described in section 1320b–5(g)(1)(B) of this title, testing and treatments for COVID–19, including specialized equipment and therapies (including preventive therapies), and, without regard to the requirements of section 1396a(a)(10)(B) of this title (relating to comparability), in the case of an individual who is diagnosed with or presumed to have COVID–19, during the period such individual has (or is presumed to have) COVID–19, the treatment of a condition that may seriously complicate the treatment of COVID–19, if otherwise covered under the State plan (or waiver of such plan);[inserted: and (G)(i) with respect to an individual who is at increased risk of breast cancer (as determined in accordance with the most recent applicable American College of Radiology Appropriateness Criteria or the most recent applicable guidelines of the National Comprehensive Cancer Network) or with heterogeneously or extremely dense breast tissue (as defined by the Breast Imaging Reporting and Data System established by the American College of Radiology), in addition to any other item or service described in this subsection, screening and diagnostic imaging for the detection of breast cancer, including 2D or 3D mammograms, breast ultrasounds, breast magnetic resonance imaging, molecular breast imaging, contrast-enhanced mammography, or other technologies (as determined in accordance with such applicable criteria or guidelines) furnished not more frequently than is recommended in guidelines set forth by the National Comprehensive Cancer Network; and (ii) with respect to an individual who is not described in clause (i) and who is determined by a health care provider (in accordance with such most recent applicable criteria or guidelines) to require screening or diagnostic breast imaging by reason of factors, including age, race, ethnicity, or personal or family medical history, screening and diagnostic imaging for the detection of breast cancer, including 2D or 3D mammograms, breast ultrasounds, breast magnetic resonance imaging, molecular breast imaging, contrast-enhanced mammography, or other technologies (as determined in accordance with such applicable criteria or guidelines) furnished not more frequently than is recommended in guidelines set forth by the National Comprehensive Cancer Network;]

(5)

(A) physicians’ services furnished by a physician (as defined in section 1395x(r)(1) of this title), whether furnished in the office, the patient’s home, a hospital, or a nursing facility, or elsewhere, and (B) medical and surgical services furnished by a dentist (described in section 1395x(r)(2) of this title) to the extent such services may be performed under State law either by a doctor of medicine or by a doctor of dental surgery or dental medicine and would be described in clause (A) if furnished by a physician (as defined in section 1395x(r)(1) of this title);

§ 1396d(a)Medical assistance(12)–(13)

(a)(6)–(11) unchanged ·

(12) prescribed drugs, dentures, and prosthetic devices; and eyeglasses prescribed by a physician skilled in diseases of the eye or by an optometrist, whichever the individual may select;

(13) other diagnostic, screening, preventive, and rehabilitative services[inserted: (other than an item or service for which medical assistance is provided pursuant to paragraph (4)(G))], including—

(A) any clinical preventive services that are assigned a grade of A or B by the United States Preventive Services Task Force;

(B) with respect to an adult individual, approved vaccines recommended by the Advisory Committee on Immunization Practices (an advisory committee established by the Secretary, acting through the Director of the Centers for Disease Control and Prevention) and their administration; and

Rest of § 1396d unchanged ·

42 U.S.C. § 1396o Use of enrollment fees, premiums, deductions, cost sharing, and similar charges

+6 −24 of 6 shown
More for 42 U.S.C. § 1396o
Read § 1396oOnly this section
6 changes the bill asks for here, 4 carried out
  1. Carried out:

    in subparagraph (I), by striking or at the end;

  2. Not carried out:

    in subparagraph (J), by striking at the end ; and and inserting , or; and

    We can't read how this instruction is worded yet, so it isn't shown in the text.

    Technical detailno-pattern: striking at the end QTEXT and inserting QTEXT; and
  3. Carried out:

    by adding at the end the following subparagraph:(K) screening and diagnostic imaging and other technologies described in clause (i) or (ii) of section 1904(a)(4)(G) furnished not more frequently than is recommended in guidelines set forth by the National Comprehensive Cancer Network to an individual described in such clause (i) or (ii), respectively; and; and

  4. Carried out:

    in subparagraph (I), by striking or at the end;

  5. Not carried out:

    in subparagraph (J), by striking at the end ; and and inserting , or; and

    We can't read how this instruction is worded yet, so it isn't shown in the text.

    Technical detailno-pattern: striking at the end QTEXT and inserting QTEXT; and
  6. Carried out:

    by adding at the end the following subparagraph:(K) screening and diagnostic imaging and other technologies described in clause (i) or (ii) of section 1904(a)(4)(G) furnished not more frequently than is recommended in guidelines set forth by the National Comprehensive Cancer Network to an individual described in such clause (i) or (ii), respectively; and.

§ 1396o(a)–(b)

Start of § 1396o to (a)(2)(G) unchanged ·

(H) during the period beginning on March 11, 2021, and ending on the last day of the first calendar quarter that begins one year after the last day of the emergency period described in section 1320b–5(g)(1)(B) of this title, a COVID–19 vaccine and the administration of such vaccine (for any individual eligible for medical assistance for such vaccine (and administration)),

(I) during the period beginning on March 11, 2021, and ending on the last day of the first calendar quarter that begins one year after the last day of the emergency period described in section 1320b–5(g)(1)(B) of this title, testing and treatments for COVID–19, including specialized equipment and therapies (including preventive therapies), and, in the case of an individual who is diagnosed with or presumed to have COVID–19, during the period during which such individual has (or is presumed to have) COVID–19, the treatment of a condition that may seriously complicate the treatment of COVID–19, if otherwise covered under the State plan (or waiver of such plan),[struck: or]

(J) vaccines described in section 1396d(a)(13)(B) of this title and the administration of such vaccines; and

(K) [inserted: screening and diagnostic imaging and other technologies described in clause (i) or (ii) of section 1904(a)(4)(G) furnished not more frequently than is recommended in guidelines set forth by the National Comprehensive Cancer Network to an individual described in such clause (i) or (ii), respectively; and]

(3) any deduction, cost sharing, or similar charge imposed under the plan with respect to other such individuals or other care and services will be nominal in amount (as determined by the Secretary in regulations which shall, if the definition of “nominal” under the regulations in effect on July 1, 1982 is changed, take into account the level of cash assistance provided in such State and such other criteria as the Secretary determines to be appropriate); except that a deduction, cost-sharing, or similar charge of up to twice the nominal amount established for outpatient services may be imposed by a State under a waiver granted by the Secretary for services received at a hospital emergency room if the services are not emergency services (referred to in paragraph (2)(D)) and the State has established to the satisfaction of the Secretary that individuals eligible for services under the plan have actually available and accessible to them alternative sources of nonemergency, outpatient services.

(b) Imposition of certain charges under plan in case of individuals other than those described in section 1396a(a)(10)(A) or (E) The State plan shall provide that in the case of individuals other than those described in subparagraph (A) or (E) of section 1396a(a)(10) of this title who are eligible under the plan—

§ 1396o(b)–(c)

(b)(1)–(2) unchanged ·

(H) during the period beginning on March 11, 2021, and ending on the last day of the first calendar quarter that begins one year after the last day of the emergency period described in section 1320b–5(g)(1)(B) of this title, a COVID–19 vaccine and the administration of such vaccine (for any individual eligible for medical assistance for such vaccine (and administration)),

(I) during the period beginning on March 11, 2021, and ending on the last day of the first calendar quarter that begins one year after the last day of the emergency period described in section 1320b–5(g)(1)(B) of this title, testing and treatments for COVID–19, including specialized equipment and therapies (including preventive therapies), and, in the case of an individual who is diagnosed with or presumed to have COVID–19, during the period during which such individual has (or is presumed to have) COVID–19, the treatment of a condition that may seriously complicate the treatment of COVID–19, if otherwise covered under the State plan (or waiver of such plan),[struck: or]

(J) vaccines described in section 1396d(a)(13)(B) of this title and the administration of such vaccines; and

(K) [inserted: screening and diagnostic imaging and other technologies described in clause (i) or (ii) of section 1904(a)(4)(G) furnished not more frequently than is recommended in guidelines set forth by the National Comprehensive Cancer Network to an individual described in such clause (i) or (ii), respectively; and]

(3) any deduction, cost sharing, or similar charge imposed under the plan with respect to other such individuals or other care and services will be nominal in amount (as determined by the Secretary in regulations which shall, if the definition of “nominal” under the regulations in effect on July 1, 1982 is changed, take into account the level of cash assistance provided in such State and such other criteria as the Secretary determines to be appropriate); except that a deduction, cost-sharing, or similar charge of up to twice the nominal amount established for outpatient services may be imposed by a State under a waiver granted by the Secretary for services received at a hospital emergency room if the services are not emergency services (referred to in paragraph (2)(D)) and the State has established to the satisfaction of the Secretary that individuals eligible for services under the plan have actually available and accessible to them alternative sources of nonemergency, outpatient services.

(c) Imposition of monthly premium; persons affected; amount; prepayment; failure to pay; use of funds from other programs

Rest of § 1396o unchanged ·

42 U.S.C. § 1396o–1 State option for alternative premiums and cost sharing

+2 −0Shown
More for 42 U.S.C. § 1396o–1
Read § 1396o–1Only this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 1916A(b)(3)(B) of the Social Security Act (42 U.S.C. 1396o–1(b)(3)(B)) is amended by adding at the end the following new clause:(xv) Screening and diagnostic imaging and other technologies described in clause (i) or (ii) of section 1904(a)(4)(G) furnished not more frequently than is recommended in guidelines set forth by the National Comprehensive Cancer Network to an individual described in such clause (i) or (ii), respectively..

§ 1396o–1(b)Limitations on exercise of authority(3)–(4)

Start of § 1396o–1 to (b)(3)(B)(xii) unchanged ·

(xiii) During the period beginning on March 11, 2021, and ending on the last day of the first calendar quarter that begins one year after the last day of the emergency period described in section 1320b–5(g)(1)(B) of this title, testing and treatments for COVID–19, including specialized equipment and therapies (including preventive therapies), and, in the case of an individual who is diagnosed with or presumed to have COVID–19, during the period during which such individual has (or is presumed to have) COVID–19, the treatment of a condition that may seriously complicate the treatment of COVID–19, if otherwise covered under the State plan (or waiver of such plan).

(xiv) Vaccines described in section 1396d(a)(13)(B) of this title and the administration of such vaccines.

(xv) [inserted: Screening and diagnostic imaging and other technologies described in clause (i) or (ii) of section 1904(a)(4)(G) furnished not more frequently than is recommended in guidelines set forth by the National Comprehensive Cancer Network to an individual described in such clause (i) or (ii), respectively.]

(C) Construction Nothing in this paragraph shall be construed as preventing a State from exempting additional classes of individuals from premiums under this section or from exempting additional individuals or services from cost sharing under subsection (a).

(4) Determinations of family income In applying this subsection, family income shall be determined in a manner specified by the State for purposes of this subsection, including the use of such disregards as the State may provide. Family income shall be determined for such period and at such periodicity as the State may provide under this subchapter.

Rest of § 1396o–1 unchanged ·

42 U.S.C. § 1396u–7 State flexibility in benefit packages

+2 −0Shown
More for 42 U.S.C. § 1396u–7
Read § 1396u–7Only this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 1937(b) of the Social Security Act (42 U.S.C. 1396u–7(b)) is amended by adding at the end the following new paragraph:(9) Coverage of certain breast cancer screening and diagnostic imaging for certain individuals.— Notwithstanding the previous provisions of this section, a State may not provide for medical assistance through enrollment of an individual with benchmark coverage or …

§ 1396u–7(b)–(c)

Start of § 1396u–7 to (b)(8) unchanged ·

(A) COVID–19 vaccines and administration of the vaccines; and

(B) testing and treatments for COVID–19, including specialized equipment and therapies (including preventive therapies), and, in the case of such an individual who is diagnosed with or presumed to have COVID–19, during the period such individual has (or is presumed to have) COVID–19, the treatment of a condition that may seriously complicate the treatment of COVID–19, if otherwise covered under the State plan (or waiver of such plan).

(9) [inserted: Coverage of certain breast cancer screening and diagnostic imaging for certain individuals.—] [inserted: Notwithstanding the previous provisions of this section, a State may not provide for medical assistance through enrollment of an individual with benchmark coverage or benchmark-equivalent coverage under this section unless such coverage includes medical assistance for screening and diagnostic imaging and other technologies described in clause (i) or (ii) of section 1904(a)(4)(G) furnished at such frequency as is recommended in guidelines set forth by the National Comprehensive Cancer Network to an individual described in such clause (i) or (ii), respectively.]

(c) Publication of provisions affected With respect to a State plan amendment to provide benchmark benefits in accordance with subsections (a) and (b) that is approved by the Secretary, the Secretary shall publish on the Internet website of the Centers for Medicare & Medicaid Services, a list of the provisions of this subchapter that the Secretary has determined do not apply in order to enable the State to carry out the plan amendment and the reason for each such determination on the date such approval is made, and shall publish such list in the Federal Register and2 not later than 30 days after such date of approval.

42 U.S.C. § 18011 Preservation of right to maintain existing coverage

+1 −1Shown
More for 42 U.S.C. § 18011
Read § 18011Only this section
Step through the changes